Characterization of the Neuroprotective Potential of Derivatives of the Iron Chelating Drug Deferiprone
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of the Neuroprotective Potential of Derivatives of the Iron Chelating Drug Deferiprone
Authors
Keywords
Oxidative stress, MAP kinases, ATP, Nerve cells, Reactive oxygen species
Journal
NEUROCHEMICAL RESEARCH
Volume 40, Issue 3, Pages 609-620
Publisher
Springer Nature
Online
2015-01-05
DOI
10.1007/s11064-014-1508-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Back to the Future with Phenotypic Screening
- (2014) Marguerite Prior et al. ACS Chemical Neuroscience
- Iron Chelation and Multiple Sclerosis
- (2014) Kelsey J. Weigel et al. ASN Neuro
- Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice
- (2013) Antonio Currais et al. AGING CELL
- Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin
- (2013) Jennifer L. Ehren et al. BIOCHEMICAL PHARMACOLOGY
- Potential clinical applications of chelating drugs in diseases targeting transferrin-bound iron and other metals
- (2013) Christina N Kontoghiorghe et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Modulation of 5-Lipoxygenase in Proteotoxicity and Alzheimer's Disease
- (2013) E. Valera et al. JOURNAL OF NEUROSCIENCE
- Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
- (2013) T. Wyss-Coray et al. Cold Spring Harbor Perspectives in Medicine
- A delicate balance: Iron metabolism and diseases of the brain
- (2013) Dominic Hare et al. Frontiers in Aging Neuroscience
- Functional Consequences of Age-Dependent Changes in Glutathione Status in the Brain
- (2012) Antonio Currais et al. ANTIOXIDANTS & REDOX SIGNALING
- Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease
- (2012) Gözde Eskici et al. BIOCHEMISTRY
- Chelating Agents for Neurodegenerative Diseases
- (2012) R. J. Ward et al. CURRENT MEDICINAL CHEMISTRY
- Bioenergetics failure in neurodegenerative diseases: back to the future
- (2012) Uday Saxena EXPERT OPINION ON THERAPEUTIC TARGETS
- Brain iron accumulation in aging and neurodegenerative disorders
- (2012) Jesper Hagemeier et al. Expert Review of Neurotherapeutics
- Metallostasis in Alzheimer's disease
- (2012) Scott Ayton et al. FREE RADICAL BIOLOGY AND MEDICINE
- An alternative approach to drug discovery for Alzheimer’s disease dementia
- (2012) David Schubert et al. Future Medicinal Chemistry
- The Flavonoid Fisetin Attenuates Postischemic Immune Cell Infiltration, Activation and Infarct Size after Transient Cerebral Middle Artery Occlusion in Mice
- (2012) Mathias Gelderblom et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Multi-target, Neuroprotective and Neurorestorative M30 Improves Cognitive Impairment and Reduces Alzheimer's-Like Neuropathology and Age-Related Alterations in Mice
- (2012) Lana Kupershmidt et al. MOLECULAR NEUROBIOLOGY
- A pilot trial of deferiprone for neurodegeneration with brain iron accumulation
- (2011) G. Abbruzzese et al. HAEMATOLOGICA
- Chemical Modification of the Multitarget Neuroprotective Compound Fisetin
- (2011) Chandramouli Chiruta et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease
- (2011) Qi Chen et al. PLoS One
- Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders
- (2010) Silvio R. Bareggi et al. CNS Neuroscience & Therapeutics
- The Effect of Iron(III) on the Activity of Selenoenzymes and Oxidative Damage in the Liver of Rats. Interaction with Natural Antioxidants and Deferiprone
- (2010) Anna Hodková et al. HEMOGLOBIN
- ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease
- (2010) Pamela Maher et al. HUMAN MOLECULAR GENETICS
- Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke
- (2010) Paul A. Lapchak et al. JOURNAL OF NEUROCHEMISTRY
- Brain iron deposits are associated with general cognitive ability and cognitive aging
- (2010) Lars Penke et al. NEUROBIOLOGY OF AGING
- Risk/Benefit Assessment, Advantages Over Other Drugs and Targeting Methods in the Use of Deferiprone as a Pharmaceutical Antioxidant in Iron Loading and Non Iron Loading Conditions
- (2009) George J. Kontoghiorghes et al. HEMOGLOBIN
- Potential Neuroprotective Drugs in Cerebral Ischemia: New Saturated and Polyunsaturated Lipids Coupled to Hydrophilic Moieties: Synthesis and Biological Activity
- (2009) Alain César Biraboneye et al. JOURNAL OF MEDICINAL CHEMISTRY
- Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxonein vitro
- (2009) Jan Lewerenz et al. JOURNAL OF NEUROCHEMISTRY
- Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation
- (2008) O. Kakhlon et al. BLOOD
- Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models
- (2008) Joshua A. Sonnen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells
- (2008) Francisco Molina-Holgado et al. JOURNAL OF NEUROCHEMISTRY
- A broadly neuroprotective derivative of curcumin
- (2008) Yuanbin Liu et al. JOURNAL OF NEUROCHEMISTRY
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now